Anglo-French Drugs & Industries Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 1.23 Cr
as on 11-07-2024
- Company Age 101 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.81 Cr
as on 11-07-2024
- Satisfied Charges ₹ 68.40 Cr
as on 11-07-2024
- Revenue -33.52%
(FY 2023)
- Profit 13068.28%
(FY 2023)
- Ebitda -606.36%
(FY 2023)
- Net Worth 1032.45%
(FY 2023)
- Total Assets 183.17%
(FY 2023)
About Anglo-French Drugs & Industries
The Corporate was formerly known as The Anglo-French Drug Company (Eastern) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.23 Cr.
The company currently has active open charges totaling ₹13.81 Cr. The company has closed loans amounting to ₹68.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Anglo-French Drugs & Industries Limited India are Sriee Aneetha as COMPANY SECRETARY and Nirbhay Kanoria as Cfo. Abhay Kanoria, Uddhav Kanoria, Ahmedali Nalagath, and Five other members serve as directors at the Company.
- CIN/LLPIN
L24230KA1923PLC010205
- Company No.
010205
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Feb 1923
- Date of AGM
03 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Anglo-French Drugs & Industries Limited offer?
Anglo-French Drugs & Industries Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Mineral Supplement, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Iron Folic Acid Tablet, Diclofenac, Diclofenac Paracetamol Tablet, Pain Killers, Forte Tablets.
Who are the key members and board of directors at Anglo-French Drugs & Industries?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Kanoria  | Managing Director | 01-Mar-1997 | Current |
| Sriee Aneetha | Company Secretary | 16-Aug-2022 | Current |
| Nirbhay Kanoria | CFO | 29-Jan-2024 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uddhav Kanoria | Whole-Time Director | 10-Aug-2006 | Current |
| Ahmedali Nalagath | Director | 24-Aug-2012 | Current |
| Nirbhay Kanoria | Director | 01-Feb-2017 | Current |
| Pradeep Joshi | Director | 11-Apr-2024 | Current |
| Rohit Choraria | Director | 09-May-2023 | Current |
| Rakesh Kanyadi | Director | 13-Aug-2019 | Current |
Financial Performance and Corporate Structure Insights of Anglo-French Drugs & Industries.
Anglo-French Drugs & Industries Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.52% decrease. The company also saw a substantial improvement in profitability, with a 13068.28% increase in profit. The company's net worth Soared by an impressive increase of 1032.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anglo-French Drugs & Industries?
In 2022, Anglo-French Drugs & Industries had a promoter holding of 64.64% and a public holding of 35.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Radha Kesari Spinning Mills LimitedActive 45 years 2 monthsAbhay Kanoria and Uddhav Kanoria are mutual person
- Broach Textile Mills Limited (Fullfledged Public Co )Active 66 years 10 months
Abhay Kanoria, Uddhav Kanoria and 1 more are mutual person
- Sudarshan Exports LimitedActive 21 years 3 months
Abhay Kanoria and Uddhav Kanoria are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Sep 2019 | ₹1.12 M | Open |
Yes Bank Limited Creation Date: 07 Feb 2017 | ₹13.70 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jul 2021 | ₹7.00 M | Satisfied |
How Many Employees Work at Anglo-French Drugs & Industries?
Anglo-French Drugs & Industries has a workforce of 252 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anglo-French Drugs & Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anglo-French Drugs & Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
